237
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Transarterial Chemoembolization Combined with Atezolizumab Plus Bevacizumab or Lenvatinib for Unresectable Hepatocellular Carcinoma: A Propensity Score Matched Study

, , , ORCID Icon, , & ORCID Icon show all
Pages 1195-1206 | Received 04 May 2023, Accepted 20 Jul 2023, Published online: 25 Jul 2023